tiprankstipranks
Trending News
More News >
Pharming Group Nv (PHAR)
:PHAR
US Market

Pharming Group (PHAR) Technical Analysis

Compare
131 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Pharming Group Nv’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.30, suggesting Pharming Group Nv is a Sell.
Pharming Group Nv’s (PHAR) 20-Day exponential moving average is 9.09, while Pharming Group Nv’s (PHAR) share price is $9.15, making it a Buy.
Pharming Group Nv’s (PHAR) 50-Day exponential moving average is 8.82, while Pharming Group Nv’s (PHAR) share price is $9.15, making it a Buy.

Pharming Group (PHAR) Pivot Points

May 17, 2025, 07:53 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.63
8.89
9.02
9.28
9.41
9.67
9.80
Fibonacci
8.89
9.04
9.13
9.28
9.43
9.52
9.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

May 17, 2025, 07:53 AM
Period
Simple
Exponential
MA5
9.60Sell
9.41Sell
MA10
9.44Sell
9.34Sell
MA20
8.98Buy
9.09Buy
MA50
8.60Buy
8.82Buy
MA100
8.94Buy
8.74Buy
MA200
8.50Buy
8.54Buy
Pharming Group Nv’s (PHAR) 10-Day exponential moving average is 9.34, while Pharming Group Nv’s (PHAR) share price is $9.15, making it a Sell.
Pharming Group Nv’s (PHAR) 100-Day exponential moving average is 8.74, while Pharming Group Nv’s (PHAR) share price is $9.15, making it a Buy.
Pharming Group Nv’s (PHAR) stock price is $9.15 and Pharming Group Nv’s (PHAR) 50-day simple moving average is 8.60, creating a Buy signal.
Pharming Group Nv’s (PHAR) stock price is $9.15 and Pharming Group Nv’s (PHAR) 100-day simple moving average is 8.94, creating a Buy signal.
Pharming Group Nv’s (PHAR) stock price is $9.15 and Pharming Group Nv’s (PHAR) 200-day simple moving average is 8.50, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

May 17, 2025, 07:53 AM
Name
Value
Implied Action
RSI (14)
52.17
Neutral
STOCH (9,6)
49.81
Neutral
STOCHRSI (14)
55.09
Neutral
MACD (12,26)
0.30
Sell
ADX (14)
21.36
Neutral
Williams %R
-60.98
Buy
CCI (14)
31.78
Neutral
ATR (14)
0.50
-
Ultimate Oscillator
49.46
Neutral
ROC
7.29
Buy
Pharming Group Nv’s (PHAR) Relative Strength Index (RSI) is 52.17, creating a Neutral signal.
Pharming Group Nv’s (PHAR) Trend Strength Indicator (ADX) is 21.36, creating a Neutral signal.
Pharming Group Nv’s (PHAR) Commodity Channel Index (CCI) is 31.78, creating a Neutral signal.
Pharming Group Nv’s (PHAR) Price Rate of Change (ROC) is 7.29, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 52.17, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.30, which suggests PHAR is a Sell.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 9.60, which suggests PHAR is a Sell.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 8.98, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 8.60, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 8.50, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -60.98, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 31.78, which suggests PHAR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis